Press Releases

LUND, Sweden, Jan. 22, 2020 /PRNewswire/ -- Hansa Biopharma will publish its Year-End report 2019 at 8:00 a.m. CET on February 6, 2020. All interested parties are invited to participate in a telephone conference, which will include a presentation of the interim results and a business update, on the same date at

UPPLANDS VÄSBY, Sweden, Jan. 22, 2020 /PRNewswire/ --  Envirotainer, the global market leader in secure cold chain solutions for air transport of pharmaceuticals, today announced that Eddy Cojulun joined Envirotainer as the new Chief Sales Officer (CSO) in December 2019. In his new role Eddy will repo

STOCKHOLM, Jan. 22, 2020 /PRNewswire/ -- Calliditas Therapeutics AB (publ) ("Calliditas") today announced that the EMA Paediatric Committee (PDCO) has adopted a positive opinion on the Paediatric Investigation Plan (PIP) for Nefecon for the treatment of primary IgA nephropathy (IgAN). With successful completion of the agreed PIP, Nefecon would be eligible f

STOCKHOLM, Jan. 22, 2020 /PRNewswire/ -- JANUARY 1 - DECEMBER 31, 2019 (compared with the corresponding period a year ago)Net sales increased 8.8% to SEK 128,975m (118,500) Organic net sales increased 4.5% In emerging markets, which accounted for 37% of net sales,

DAYTON, Ohio, Jan. 22, 2020 /PRNewswire/ -- Soin Neuroscience, a biotechnology company based in Dayton, OH, has developed a new spinal cord stimulation device to treat chronic pain. The company has recently started early stage human proof of concept studies. Dr Amol Soin, the founder and CEO of Soin Neurosci

SHANGHAI, Jan. 21, 2020 /PRNewswire/ -- The National Medical Products Administration (NMPA) announced the first 45 key laboratories in June 2019 and mentioned that the construction of national-level innovative key laboratories would play a guiding and demonstrated role in improving drug sci-tech innovation and scientific regulation. Therefor

ST. LOUIS, Jan. 21, 2020 /PRNewswire/ -- Centene Corporation (NYSE:CNC) ("Centene") announced today the final results of the offers to exchange (the "Exchange Offers") notes (the "WellCare Notes") issued by WellCare Health Plans, Inc. (NYSE:WCG) ("WellCare") for up to $1,950,000,000 aggregate principal amount of new notes to be iss

ST. LOUIS and TAMPA, Fla., Jan. 21, 2020 /PRNewswire/ -- Centene Corporation (NYSE: CNC) ("Centene") and WellCare Health Plans, Inc. (NYSE: WCG) ("WellCare") today announced that they now have satisfied all regulatory requirements under the merger agreement to complete the pending transaction, including review by the U.S. Depart

SANFORD, N.C., Jan. 21, 2020 /PRNewswire/ -- DisposeRx, Inc., manufacturer of the market leading at-home medication disposal solution, has in place a network of more than 1,000 pharmacies in

VORHEES, N.J., Jan. 21, 2020 /PRNewswire/ -- The Center for Neurological and Neurodevelopmental Health ("CNNH") announced today that it began mailing letters to patients potentially impacted by a recent incident. On November 22, 2019, CNNH learned of suspicious activity related to an employee's email account.  CNNH immediately took steps to secure the account an